Clinical trial
The Mass Balance Study of [14C]LP-168 in Chinese Healthy Subjects
NCT06126861 is registered in ClinicalTrials.gov with Guangzhou Lupeng Pharmaceutical Company LTD. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Mass Balance Study of [14C]LP-168 in Chinese Healthy Subjects
- Lead sponsor
- Guangzhou Lupeng Pharmaceutical Company LTD.
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- December 25, 2023
- Completion date
- March 13, 2024
- Enrollment
- 6 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
clinical pharmacology